Simplex Trading’s MaxCyte MXCT Stock Holding History

Simplex Trading’s Portfolio MXCT Stock Details MXCT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-2,900	Closed	-$4.5K	–	9769
2025 Q4	$4.5K	Sell	2,900 -2,000	-41%	-$3.19K	﹤0.01%	7490
2025 Q3	$7K	Buy	+4,900	New	+$8.52K	﹤0.01%	8124
2025 Q2	–	Sell	-600	Closed	-$1K	–	9357
2025 Q1	$1K	Sell	600 -11,100	-95%	-$43.8K	﹤0.01%	8252
2024 Q4	$48K	Buy	+11,700	New	+$44.2K	﹤0.01%	5911
2023 Q2	–	Sell	-400	Closed	-$1K	–	9575
2023 Q1	$1K	Buy	+400	New	+$1.97K	﹤0.01%	8727
2022 Q4	–	Sell	-2,400	Closed	-$15K	–	9958
2022 Q3	$15K	Sell	2,400 -3,400	-59%	-$19K	﹤0.01%	7834
2022 Q2	$27K	Buy	5,800 +400	+7%	+$1.97K	﹤0.01%	7256
2022 Q1	$37K	Buy	+5,400	New	+$36.9K	﹤0.01%	7540

Other funds holding MXCT

CFM

Capricorn Fund Managers London, United Kingdom $1.27B AUM 70.17% 1-Year Est. Return

Vitruvian Partners London, United Kingdom $201M AUM 10.44% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Mudita Advisors London, United Kingdom $481M AUM 73.74% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

BFM

Brooklands Fund Management London, United Kingdom $128M AUM

BNP Paribas Asset Management Paris, France $99.8B AUM 45.22% 1-Year Est. Return

CCM

Cadian Capital Management New York $1.32B AUM 4.19% 1-Year Est. Return

PLC

Peapod Lane Capital Bedford Hills, New York $148M AUM 89.92% 1-Year Est. Return

Simplex Trading's MXCT Position: Q2 2026 in Review

Simplex Trading reduced its MaxCyte (MXCT) stake by 62% in Q2 2026, selling an estimated $788 and leaving 476 shares worth $585. The position accounts for ﹤0.01% of the portfolio, ranked #8928.

Simplex Trading first reported a position in MXCT in Q4 2022 and has held it in 10 quarters since. The position peaked at $13K in Q3 2024. 123 funds tracked by Wall St. Rank hold MXCT as of Q2 2026.

Simplex Trading held 476 shares of MaxCyte worth $585 as of Q2 2026.
Simplex Trading sold 791 MaxCyte shares in Q2 2026, an estimated $788.
MaxCyte made up ﹤0.01% of Simplex Trading's portfolio in Q2 2026, its #8928 holding.
Simplex Trading first reported a position in MaxCyte in Q4 2022 and has held it in 10 quarters since.
Simplex Trading's MaxCyte position peaked at $13K in Q3 2024.
123 funds tracked by Wall St. Rank held MaxCyte as of Q2 2026.

Based on Simplex Trading's 13F filing for Q2 2026, filed 12 Aug 2026.